Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for advanced cancer: KQB198 trial launches

NCT ID NCT06507306

Ongoing Disease control Sponsor: Kumquat Biosciences Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 29, 2026 · Updated 2 times

Summary

This early-phase trial tests a new drug called KQB198 in adults with advanced solid tumors that have not responded to other treatments. The study aims to find a safe dose and see if KQB198 can shrink tumors when used alone or with other cancer drugs. About 100 participants will take the drug daily and have regular clinic visits for monitoring.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neoplasm non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SOLID TUMOR, ADULT

Contacts and locations

Locations

  • CHU Bordeaux - Hopital Saint-Andre

    Bordeaux, Nouvelle-Aquitane, 33000, France

  • CHU de Nantes - Hopital Nord Laennec

    Nantes, Pays de la Loire Region, 44000, France

  • Clinica Universidad de Navarra - Pamplona

    Pamplona, 31008, Spain

  • David H. Koch Center for Cancer Center at Memorial Sloan Kettering Cancer Center

    Long Island City, New York, 11101, United States

  • Florida Cancer Specialists - Sarasota

    Sarasota, Florida, 34232, United States

  • Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore

    Rome, Lazio, 00168, Italy

  • Henry Ford Health System

    Detroit, Michigan, 48202, United States

  • Hospital Quirónsalud Málaga

    Málaga, 29004, Spain

  • Hospital Universitari Quiron Dexeus Barcelona

    Barcelona, Catalonia, 08028, Spain

  • Hospital Universitario Ramon y Cajal

    Madrid, 28034, Spain

  • Hospital Universitario Vall d'Hebron

    Barcelona, Catalonia, 08035, Spain

  • IUCT-Oncopole

    Toulouse, Occitaine, 31059, France

  • Institut Paoli-Calmettes

    Marseille, Bouches-du-Rhône, 13009, France

  • Institut de Cancerologie de l'Ouest - site St-Herblain

    Saint-Herblain, Loire-Atlantique, 44800, France

  • Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

    Naples, 80131, Italy

  • New Experimental Therapeutics (NEXT) Oncology Barcelona

    Barcelona, 08023, Spain

  • New Experimental Therapeutics (NEXT) Oncology Madrid - Hospital Quironsalud Madrid

    Madrid, 28223, Spain

  • New Experimental Therapeutics of San Antonio - NEXT Oncology

    San Antonio, Texas, 78229, United States

  • New Experimental Therapeutics of Virginia - NEXT Oncology

    Fairfax, Virginia, 22031, United States

  • Sarah Cannon Research Institute at Florida Cancer Specialists - Lake Nona -

    Orlando, Florida, 32827, United States

  • Sarah Cannon Research Institute at HealthONE

    Denver, Colorado, 80218, United States

  • Sarah Cannon and HCA Research Institute

    Nashville, Tennessee, 37203, United States

  • South Texas Accelerated Research Therapeutics (START) Barcelona- HM Nou Delfos

    Barcelona, 08023, Spain

  • South Texas Accelerated Research Therapeutics (START) Madrid - CIOCC

    Madrid, 28040, Spain

  • South Texas Accelerated Research Therapeutics (START) Madrid - Hospital Fundacion Jimenez Diaz

    Madrid, Spain

  • The Lindner Center for Research and Education at The Christ Hospital

    Cincinnati, Ohio, 45219, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.